ARID1A and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), subunit‐specific perturbations demonstrate oncogenic consequences: ARID1A (BAF250a) inactivation promotes metastatic progression via steatosis‐associated genomic instability [19].